Patients Being Recruited for Phase 2 Trial of Keytruda and Chemoradiation in Cervical Cancer
News
Cervical cancer patients are being recruited for a Phase 2 clinical trial of a combination of Keytruda (pembrolizumab) and chemoradiation therapy. The randomized trial (NCT02635360) is expected to include about 88 ... Read more